We are live on ! Find out more
Aberdeen Group

Aberdeen Group Portfolio holdings

AUM $61.9B
1-Year Est. Return 29.81%
This Fund
S&P 500
This Quarter Est. Return
+5.07%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
AUM
$64.6B
AUM Growth
+$1.37B
Cap. Flow
-$686M
Cap. Flow %
-1.06%
Top 10 Hldgs %
38.17%
Holding
995
New
43
Increased
362
Reduced
491
Closed
59

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$36.3M
2
SCHW
Charles Schwab
SCHW
+$36.1M
3
ASND icon
Ascendis Pharma A/S
ASND
+$35.6M
4
DHR icon
Danaher
DHR
+$30.5M
5
QURE icon
uniQure
QURE
+$28.5M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$93.5M
2
MELI icon
Mercado Libre
MELI
+$86M
3
MSFT icon
Microsoft
MSFT
+$62.9M
4
AAPL icon
Apple
AAPL
+$55.6M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$48.9M

Sector Composition

Rank Sector Weight
1 Technology 32.59%
2 Healthcare 13.39%
3 Consumer Discretionary 11.41%
4 Communication Services 11.25%
5 Financials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARES icon
451
Ares Management
ARES
$28B
$19M 0.03%
117,705
+10,546
+10% +$1.64M
ANIP icon
452
ANI Pharmaceuticals
ANIP
$1.83B
$19M 0.03%
240,792
-28,886
-11% -$2.5M
ARWR icon
453
Arrowhead Research
ARWR
$12.3B
$19M 0.03%
286,146
-234,498
-45% -$11.5M
WK icon
454
Workiva
WK
$3.29B
$18.8M 0.03%
218,382
-13,390
-6% -$1.19M
EQT icon
455
EQT Corp
EQT
$33B
$18.8M 0.03%
350,107
-2,021
-0.6% -$114K
CFG icon
456
Citizens Financial Group
CFG
$30.3B
$18.7M 0.03%
319,712
-1,131
-0.4% -$60.8K
IRON icon
457
Disc Medicine
IRON
$3.03B
$18.6M 0.03%
234,358
+202,297
+631% +$17.1M
CXW icon
458
CoreCivic
CXW
$2.95B
$18.5M 0.03%
968,300
+363,526
+60% +$6.66M
ODFL icon
459
Old Dominion Freight Line
ODFL
$44.2B
$18.4M 0.03%
117,589
+11,410
+11% +$1.64M
AZZ icon
460
AZZ Inc
AZZ
$4.36B
$18.4M 0.03%
+171,945
New +$17.8M
GPCR icon
461
Structure Therapeutics
GPCR
$3.52B
$18.4M 0.03%
264,869
-322,000
-55% -$13.1M
CDW icon
462
CDW
CDW
$18.6B
$18.3M 0.03%
134,662
+6,171
+5% +$910K
CWST icon
463
Casella Waste Systems
CWST
$5.69B
$18.3M 0.03%
186,992
+82,616
+79% +$7.67M
DGX icon
464
Quest Diagnostics
DGX
$25.9B
$18.2M 0.03%
104,886
-775
-0.7% -$141K
WST icon
465
West Pharmaceutical
WST
$23.9B
$18.1M 0.03%
65,628
-1,181
-2% -$323K
BANR icon
466
Banner Corp
BANR
$2.37B
$18M 0.03%
287,398
-14,409
-5% -$910K
KIM icon
467
Kimco Realty
KIM
$17.2B
$17.9M 0.03%
883,798
+11,908
+1% +$247K
AXSM icon
468
Axsome Therapeutics
AXSM
$12.1B
$17.8M 0.03%
97,413
+2,765
+3% +$386K
SBRA icon
469
Sabra Healthcare REIT
SBRA
$5.38B
$17.8M 0.03%
938,098
+16,960
+2% +$314K
IT icon
470
Gartner
IT
$10.2B
$17.8M 0.03%
70,386
-2,356
-3% -$567K
OSW icon
471
OneSpaWorld
OSW
$2.64B
$17.7M 0.03%
+851,646
New +$17.8M
RJF icon
472
Raymond James Financial
RJF
$33.6B
$17.6M 0.03%
109,571
-7,421
-6% -$1.2M
ADMA icon
473
ADMA Biologics
ADMA
$2.01B
$17.6M 0.03%
963,949
-152,363
-14% -$2.57M
VST icon
474
Vistra
VST
$50.1B
$17.6M 0.03%
108,842
-1,217
-1% -$222K
DLTR icon
475
Dollar Tree
DLTR
$24.7B
$17.5M 0.03%
141,935
+2,311
+2% +$248K

Similar funds

Aberdeen Group's Q4 2025 Portfolio in Review

As of Q4 2025, Aberdeen Group held 995 positions worth $64.6B, up 2.2% from $63.2B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Aberdeen Group's Q4 2025 filing shows 43 new, 362 increased, 491 reduced and 59 closed positions. Its largest new stake was Praxis Precision Medicines: 134,992 shares worth $39.8M. The largest sale was Eli Lilly, an estimated $93.5M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Aberdeen Group's largest Q4 2025 buy was Praxis Precision Medicines: 134,992 shares worth $39.8M.
  • Aberdeen Group added most to Nu Holdings in Q4 2025, an estimated $36.3M increase.
  • Aberdeen Group's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $93.5M.
  • Aberdeen Group fully exited BioMarin Pharmaceuticals in Q4 2025, selling an estimated $48.9M.
  • Aberdeen Group's ten largest holdings make up 38% of its $64.6B portfolio in Q4 2025.
  • Aberdeen Group opened 43 new positions and closed 59 in Q4 2025.
  • Aberdeen Group's portfolio value rose 2.2% quarter-over-quarter to $64.6B.

Based on Aberdeen Group's 13F filing for Q4 2025, filed 16 Jan 2026.